Progesterone for the treatment of central nervous system disorders: the many signaling roads for a single molecule

Progesterone for the treatment of central nervous system disorders: the many signaling roads for a single molecule

Bibliographic Details
Main Author:	Susana Laura Gonzalez
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2020-01-01
Series:	Neural Regeneration Research
Online Access:	http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=10;spage=1846;epage=1847;aulast=Gonzalez

Similar Items

Progesterone Actions During Central Nervous System Development
by: Juan Carlos González-Orozco, et al.
Published: (2019-05-01)

Roles of Progesterone, Testosterone and Their Nuclear Receptors in Central Nervous System Myelination and Remyelination
by: Abdel Mouman Ghoumari, et al.
Published: (2020-04-01)

The Many Hats of Sonic Hedgehog Signaling in Nervous System Development and Disease
by: Yesser H. Belgacem, et al.
Published: (2016-12-01)

Regenerative medicine for central nervous system disorders: Role of therapeutic molecules in stem cell therapy
by: Paola Suárez-Meade, et al.
Published: (2015-01-01)

Zinc and Central Nervous System Disorders
by: Bangqi Wang, et al.
Published: (2023-04-01)

Mitochondria and Central Nervous System Disorders
by: Tomas Knedlik, et al.
Published: (2022-10-01)

Progesterone synthesis in the nervous system: implications for myelination and myelin repair
by: Michael eSchumacher, et al.
Published: (2012-02-01)

Disorders of the central nervous system: Insights from Notch and Nrf2 signaling
by: Yuwen Chen, et al.
Published: (2023-10-01)

Progesterone effects on the oligodendrocyte linage: all roads lead to the progesterone receptor
by: Ignacio Jure, et al.
Published: (2019-01-01)

Nucleic acid-based therapeutics for the treatment of central nervous system disorders
by: Robyn McCartan, et al.
Published: (2023-08-01)

On the road to new treatments for multiple sclerosis: targeting dendritic cell migration into the central nervous system
by: Megha Meena, et al.
Published: (2019-01-01)

N-acetylaspartate : a unique neuronal molecule in the central nervous system /
by: Moffett, John R., et al.
Published: (2006)

Application of Small Molecules in the Central Nervous System Direct Neuronal Reprogramming
by: Jingyi Wang, et al.
Published: (2022-07-01)

Autoantibody-mediated disorders of the central nervous system.
by: Irani, S, et al.
Published: (2008)

Editorial: Proteostasis in central nervous system disorders
by: An Zhou, et al.
Published: (2024-03-01)

Central nervous system autoimmunity in neuropsychiatric disorders
by: Coutinho, M
Published: (2016)

Medicinal Cannabis and Central Nervous System Disorders
by: Yuma T. Ortiz, et al.
Published: (2022-04-01)

Senescence in aging and disorders of the central nervous system
by: Barbara L. Swenson, et al.
Published: (2019-01-01)

Relationship between age and progesterone receptor expression with presence of central nervous system metastases in breast invasive ductal carcinoma
by: Eduardo Cambruzzi, et al.
Published: (2015-10-01)

Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System
by: Andersen O, et al.
Published: (2023-07-01)

MicroRNAs in central nervous system disorders: current advances in pathogenesis and treatment
by: Mona Hussein, et al.
Published: (2021-03-01)

HIGH GRADE GLIOMA OF CENTRAL NERVOUS SYSTEM: SINGLE CENTER TREATMENT EXPERIENCE
by: Nur OLGUN, et al.
Published: (2021-11-01)

The many roads to tremor.
by: Brittain, J, et al.
Published: (2013)

Experimental and Computational Methods to Assess Central Nervous System Penetration of Small Molecules
by: Mayuri Gupta, et al.
Published: (2024-03-01)

In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system.
by: Nóra Gampe, et al.
Published: (2022-01-01)

In vitro and in silico evaluation of Ononis isoflavonoids as molecules targeting the central nervous system
by: Nóra Gampe, et al.
Published: (2022-01-01)

Delivery of Adeno-Associated Virus Vectors to the Central Nervous System for Correction of Single Gene Disorders
by: Rrita Daci, et al.
Published: (2024-01-01)

New autoantibody mediated disorders of the central nervous system.
by: Lang, B, et al.
Published: (2003)

Beneficial Effects of Capsaicin in Disorders of the Central Nervous System
by: Michał Pasierski, et al.
Published: (2022-04-01)

C1q and central nervous system disorders
by: Wenjie Zhang, et al.
Published: (2023-03-01)

Congenital and acquired mitochondrial disorders of the central nervous system
by: V. V. Nikitina, et al.
Published: (2014-12-01)

Microglia as therapeutic target in central nervous system disorders
by: Oluwaseun Fatoba, et al.
Published: (2020-11-01)

Anxiety disorders in acute central nervous system infections
by: Elena Bozzola, et al.
Published: (2020-02-01)

Clinical proton MR spectroscopy in central nervous system disorders.
by: Oz, G, et al.
Published: (2014)

INSULIN AND INSULIN RESISTANCE: NEW MOLECULE MARKERS AND TARGET MOLECULE FOR THE DIAGNOSIS AND THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM
by: A. B. Salmina, et al.
Published: (2013-10-01)

Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions
by: Gabriel Nascimento-dos-Santos, et al.
Published: (2021-07-01)

Treatment of primary central nervous system lymphomas
by: I. V. Cherkashina, et al.
Published: (2021-06-01)

Ketoconazole in the treatment of cryptococcosis of the central nervous system
by: P. C. Trevisol-Bittencourt, et al.
Published: (1991-06-01)

Corticosteroid Treatment for Central Nervous System Infections
by: Dong Hoon Shin
Published: (2017-12-01)

Psychiatric disorders in children with demyelinating diseases of the central nervous system
by: Pakpoor, J, et al.
Published: (2017)